|
|
Article: Merck's Propecia(TM) Cleared For Marketing: Once-A-Day Pill Offers Men Effective Treatment For Male Pattern Hair Loss
- Article from:
- PR Newswire
- Article date:
- December 22, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WEST POINT, Pa., Dec. 22 /PRNewswire/ -- New hope is on the horizon today for millions of American men who are concerned about losing their hair, and who believe there is little they can do about it. Merck & Co., Inc. (NYSE: MRK) announced that the U.S. Food and Drug Administration has granted marketing clearance to Propecia(TM) (finasteride 1 mg), the first and only pill to treat male pattern hair loss (androgenetic alopecia), for use in men only. Propecia (pronounced pro-PEE-sha) will be available by prescription only and should be on pharmacy shelves by mid-January.
The marketing clearance of Propecia is based on data from three one-year, double-blind, ...